Securities code: Jiangxi Sanxin Medtec Co.Ltd(300453) securities abbreviation: Jiangxi Sanxin Medtec Co.Ltd(300453) Announcement No.: 2022017
Jiangxi Sanxin Medtec Co.Ltd(300453)
Announcement on holding online explanation meeting of 2021 Annual Report
The company and all members of the board of directors guarantee that the contents of the announcement are true, accurate and complete without false records, misleading statements or major omissions.
Jiangxi Sanxin Medtec Co.Ltd(300453) (hereinafter referred to as "the company") was posted on cninfo.com on March 17, 2022（ http://www.cn.info.com.cn./ ）The full text of the 2021 annual report and its abstract were disclosed on the website.
In order to facilitate the majority of investors to further understand the company's annual operation in 2021, the company will hold an online performance presentation of the annual report in 2021 from 15:00 to 17:00 on Friday, March 25, 2022. The annual report presentation will be held simultaneously through the "interactive and easy" platform provided by Shenzhen Stock Exchange and the "value online" platform provided by Shenzhen Value Online Information Technology Co., Ltd.
Participation mode 1: held through the "interactive and easy" platform provided by Shenzhen Stock Exchange, investors can log in to the "interactive and easy" website（ http://irm.cn.info.com.cn. ）, enter the "cloud interview" column to participate in this performance briefing.
Participation mode 2: investors can visit the website from 15:00 to 17:00 on Friday, March 25, 2022 https://eseb.cn./TljZuYp8AM Or use wechat to scan the following QR code to participate in interactive communication. Mr. Zou Yiping, the independent director, Mr. Zhou Yiping, the general manager, Mr. Yu Zhenrong, the independent director of the board of directors, Mr. Zhou Yiping, the Secretary of the board of directors, Mr. Yu Zhenrong, the independent director of the company.
Investors are welcome to actively participate!
It is hereby announced
Jiangxi Sanxin Medtec Co.Ltd(300453) board of directors March 17, 2022
